表紙
市場調查報告書
商品編碼
979360

末梢神經病變性疼痛:全球臨床試驗檢討(2020年下半年)

Peripheral Neuropathic Pain - Global Clinical Trials Review, H2 2020

出版日期: | 出版商: GlobalData | 英文 516 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球末梢神經病變性疼痛各期關臨床研究最新趨勢各期關分析,彙整疾病·治療方法概要,及主要已開發國家·新興國家 (G7/E7各國) 的臨床實驗狀況,各地區·不同階段 (各期)·各階段的進展,有潛力的贊助商 (臨床試驗贊助者),各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

目錄

目錄

表格一覽

圖表一覽

  • 報告指南
  • 調查範圍
  • 臨床試驗:各地區
  • 臨床試驗數量與平均登記數:各國
  • 亞太地區主要5國的臨床試驗數量
  • 歐洲主要5國的臨床試驗數量
  • 北美主要5國的臨床試驗數量
  • 中東·非洲主要5國的臨床試驗數量
  • 中南美主要5國的臨床試驗數量
  • G7各國臨床試驗數量:中樞神經系統臨床試驗上末梢神經病變性疼痛的比例
  • G7各國的臨床試驗數量:各期
  • G7各國的臨床試驗數量:各臨床實驗狀況
  • 對E7各國的臨床試驗數量:中樞神經系統臨床試驗上末梢神經病變性疼痛的比例
  • E7各國的臨床試驗數量:各期
  • E7各國的臨床試驗數量:各臨床實驗狀況
  • 臨床試驗數量:各期
  • 進行中的實驗數量:各期
  • 臨床試驗數量:各臨床實驗狀況
  • 臨床試驗數量:各端點狀況
  • 連續一定期間所募集的實驗對象
  • 各贊助商類型臨床試驗數量
  • 有潛力的贊助商
  • 末梢神經病變性疼痛參加治療藥物臨床實驗的主要企業
  • 有潛力的藥劑
  • 臨床試驗專家的概述

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 2次調查
  • 關於GlobalData
  • 諮詢方式
  • 資訊來源
目錄
Product Code: GDHC6552CTIDB

GlobalData's clinical trial report, "Peripheral Neuropathic Pain - Global Clinical Trials Review H2 2020" provides an overview of Peripheral Neuropathic Pain Clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Neuropathic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Peripheral Neuropathic Pain Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Region, 2020*
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Peripheral Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Peripheral Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Peripheral Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Peripheral Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Peripheral Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Peripheral Neuropathic Pain Therapeutic